Clinical Trials Directory

Trials / Conditions / Pediatric Growth Hormone Deficiency

Pediatric Growth Hormone Deficiency

10 registered clinical trials studyying Pediatric Growth Hormone Deficiency — 2 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingA Study of GenSci134 in Children With Growth Hormone Deficiency (PGHD)
NCT07450001
Changchun GeneScience Pharmaceutical Co., Ltd.Phase 1 / Phase 2
Not Yet RecruitingA Study (Phase 1b/2) of GS3-007a Oral Treatment in Children With Growth Hormone Deficiency (PGHD)
NCT07264595
Changchun GeneScience Pharmaceutical Co., Ltd.Phase 1 / Phase 2
Active Not RecruitingKorean Post-marketing Surveillance Ngenla® Pre-filled Pen Injection for the Treatment of Pediatric Patients Wi
NCT05509894
Pfizer—
WithdrawnA Study to Compare the Experiences of Taking Daily Growth Hormone Injections to Weekly Ngenla in Children With
NCT06113952
Pfizer—
CompletedA Study to Evaluating the Efficacy and Safety of Recombinant Long-acting Human Growth Hormone (TJ101) in Child
NCT04633057
TJ Biopharma Co., Ltd.Phase 3
CompletedSafety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
NCT02968004
OPKO Health, Inc.Phase 3
TerminatedVersartis Trial in Pre-pubertal Japanese Children With Growth Hormone Deficiency (GHD) to Assess Long-Acting G
NCT02413138
Versartis Inc.Phase 2 / Phase 3
TerminatedVersartis Long-Term Safety Study of Somavaratan
NCT02068521
Versartis Inc.Phase 2 / Phase 3
CompletedVersartis Trial in Children to Assess Long-Acting Growth Hormone
NCT01718041
Versartis Inc.Phase 1 / Phase 2
CompletedSafety and Efficacy Phase 2 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
NCT01592500
OPKO Health, Inc.Phase 2